DEUTSCHE BANK AG\

Bank

Position in OCGN — Ocugen, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in OCGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$516,994

+$346,126 QoQ

Shares Held

337,905

+39.6% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 147 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. OCGN ranks #179 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$516,994	337,905	+39.6%	Shares	Defined	2026-08-07
2025-03-31	$170,868	242,023	+3799.2%	Shares	Defined	2025-05-09
2024-12-31	$4,996	6,207	-96.4%	Shares	Defined	2025-06-30
2024-09-30	$169,979	171,351	+31.3%	Shares	Defined	2025-06-26
2024-06-30	$202,337	130,541	-23.2%	Shares	Defined	2025-06-12
2023-03-31	$144,950	169,930	+48.4%	Shares	Defined	2023-05-15
2022-12-31	$148,836	114,490	-25.8%	Shares	Defined	2023-02-13
2022-09-30	$274,619	154,281	-21.3%	Shares	Defined	2022-11-14
2022-06-30	$444,751	195,926	+70.2%	Shares	Defined	2022-08-11
2022-03-31	$379,885	115,117	-9.2%	Shares	Defined	2022-05-13
2021-12-31	$576,725	126,753	-2.5%	Shares	Defined	2022-02-16
2021-09-30	$933,514	130,016	+3.9%	Shares	Defined	2021-11-04
2021-06-30	$1,004,776	125,128	—	Shares	Defined	2021-08-11
No filing history on record for this holder in this stock.